Hu Z - Search Results

1

Dynamic investigation of alveolar type II cell function in a long-term survival model of rat lung ischemia-reperfusion injury.

Feng D, Zhang S, Hu Z, Fan F, Jiang F, Yin R, Xu L. Feng D, et al. Among authors: hu z. Scand J Clin Lab Invest. 2010 Sep;70(5):364-73. doi: 10.3109/00365513.2010.495415. Scand J Clin Lab Invest. 2010. PMID: 20560845

2

Clinical experience of lobectomy with pulmonary artery reconstruction for central non-small-cell lung cancer.

Yin R, Xu L, Ren B, Jiang F, Fan X, Zhang Z, Li M, Hu Z. Yin R, et al. Among authors: hu z. Clin Lung Cancer. 2010 Mar 1;11(2):120-5. doi: 10.3816/CLC.2010.n.016. Clin Lung Cancer. 2010. PMID: 20199978

3

[Selection of Therapy Method for Stage III Non Small Cell Lung Cancer after Induction Chemotherapy.].

Hu Z, Lu J, Zhu J, Zhu L, Xu L. Hu Z, et al. Zhongguo Fei Ai Za Zhi. 2009 Aug 20;12(8):939-42. doi: 10.3779/j.issn.1009-3419.2009.08.23. Zhongguo Fei Ai Za Zhi. 2009. PMID: 20719187 Chinese.

4

[Surgical treatment for locally advanced lung cancer invading heart and great vessels].

Xu L, Yuan F, Yu M, Qiu N, Liu J, Jiang M, Huang J, Fan Z, Hu Z, Lu X. Xu L, et al. Among authors: hu z. Zhongguo Fei Ai Za Zhi. 2002 Dec 20;5(6):408-10. doi: 10.3779/j.issn.1009-3419.2002.06.03. Zhongguo Fei Ai Za Zhi. 2002. PMID: 21333216 Free article. Chinese.

5

Berberine attenuates lipopolysaccharide-induced impairments of intestinal glutamine transport and glutaminase activity in rat.

Niu L, Qiao W, Hu Z, Li N, Huang Q, Gong J, Li Q, Zhu W, Li J. Niu L, et al. Among authors: hu z. Fitoterapia. 2011 Apr;82(3):323-30. doi: 10.1016/j.fitote.2010.11.007. Epub 2010 Nov 10. Fitoterapia. 2011. PMID: 21073932

6

Association of leptin receptor polymorphisms with susceptibility of non-small cell lung cancer: Evidence from 2249 subjects.

Tang W, Wang J, Dai T, Qiu H, Liu C, Chen S, Hu Z. Tang W, et al. Among authors: hu z. Cancer Med. 2024 Apr;13(8):e7178. doi: 10.1002/cam4.7178. Cancer Med. 2024. PMID: 38659416 Free PMC article. Review.

7

Y-box-binding protein 1 promotes tumor progression and inhibits cisplatin chemosensitivity in esophageal squamous cell carcinoma.

Xu J, Hu Z. Xu J, et al. Among authors: hu z. Biomed Pharmacother. 2016 Apr;79:17-22. doi: 10.1016/j.biopha.2016.01.037. Epub 2016 Feb 9. Biomed Pharmacother. 2016. PMID: 27044807 Free article.

8

MiR-502 mediates esophageal cancer cell TE1 proliferation by promoting AKT phosphorylation.

Xu J, Pan X, Hu Z. Xu J, et al. Among authors: hu z. Biochem Biophys Res Commun. 2018 Jun 18;501(1):119-123. doi: 10.1016/j.bbrc.2018.04.188. Epub 2018 May 4. Biochem Biophys Res Commun. 2018. PMID: 29709473

9

Insights from immunomics and metabolomics on the associations between prostatic diseases and coronavirus disease 2019.

Yang F, Guo P, Wang K, Zhang X, Hu Z, Lou Q, Ge Q, Chen Y, Liang C, Meng J. Yang F, et al. Among authors: hu z. Prostate Int. 2024 Sep;12(3):167-177. doi: 10.1016/j.prnil.2024.07.003. Epub 2024 Jul 25. Prostate Int. 2024. PMID: 39816935 Free PMC article.

10

Optimized circular RNA vaccines for superior cancer immunotherapy.

Yu H, Wen Y, Yu W, Lu L, Yang Y, Liu C, Hu Z, Fang Z, Huang S. Yu H, et al. Among authors: hu z. Theranostics. 2025 Jan 2;15(4):1420-1438. doi: 10.7150/thno.104698. eCollection 2025. Theranostics. 2025. PMID: 39816687 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,389 results

Search Page

Filters